GABRA1 Gene Early Infantile Epileptic Encephalopathy Type 19 NGS Genetic DNA Test
Introduction
The GABRA1 Gene Early Infantile Epileptic Encephalopathy Type 19 NGS Genetic DNA Test is a crucial diagnostic tool for identifying genetic mutations associated with severe neurological disorders in infants. This advanced test utilizes Next Generation Sequencing (NGS) technology to provide accurate results, aiding healthcare professionals in making informed decisions regarding patient care.
What the Test Measures
This genetic test specifically detects mutations in the GABRA1 gene, which are linked to early infantile epileptic encephalopathy. By analyzing the DNA from a blood sample or extracted DNA, the test helps confirm or rule out the presence of genetic factors contributing to neurological disorders.
Who Should Consider This Test
Parents or guardians of infants exhibiting symptoms such as:
- Severe seizures
- Developmental delays
- Unexplained neurological symptoms
should consider this test. Additionally, individuals with a family history of epilepsy or neurological disorders may also benefit from genetic testing.
Benefits of Taking the Test
- Early diagnosis can lead to timely intervention and treatment.
- Understanding genetic factors can help in family planning and counseling.
- Provides clarity on the prognosis and management of the condition.
Understanding Your Results
Results from the GABRA1 Gene test will indicate whether or not a mutation is present. A positive result may suggest a genetic predisposition to epilepsy, while a negative result can provide reassurance. It is essential to discuss the results with a qualified healthcare professional who can guide you through the implications and next steps.
Test Pricing
| Price Type | Amount (KSh) |
|---|---|
| Discount Price | 40,000 |
| Regular Price | 56,000 |
Book Your Test Today!
We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu. You can also opt for our home sample collection service for your convenience. To book the GABRA1 Gene Early Infantile Epileptic Encephalopathy Type 19 NGS Genetic DNA Test, call or WhatsApp us at +254711564616.
Additional Information
Turnaround Time: 3 to 4 weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with GABRA1 Gene Early Infantile Epileptic Encephalopathy Type 19.
This test is performed under the guidance of experienced neurologists in our genetics department, ensuring high-quality care and accurate results.
